| | FDA WARNING: ORAL OSTEOPOROSIS DRUGS – POTENTIAL INCREASED CANCER RISK
According to a recent news release, the FDA has notified healthcare professionals and patients about its ongoing review of data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus. These drugs include Fosamax (alendronate), Actonel (risedronate), Boniva (ibandronate), Atelvia (risedronate delayed release), Didronel (etidronate), and Skelid (tiludronate)
The FDA has yet to make any final conclusions as to whether taking an oral bisphosphonate drug increases the risk of esophageal cancer. However, if you or a loved one has or is suffering from exophageal cancer, you should contact a Fosamax Cancer attorney immediately to preserve your legal rights.
You should continue to monitor this developing situation. The FDA will continue to evaluate all available data supporting the safety and effectiveness of bisphosphonate drugs and will continue to provide updates.
If you or a loved one has taken a osteoporosis drug, including Fosamax, and now has been diagnosed with esophageal cancer, contact a Fosamax Cancer Lawyer lawyer immediately at (888) 423-4477 begin_of_the_skype_highlighting (888) 423-4477 end_of_the_skype_highlighting or by filling out a FREE EVALUATION.
Contact us today, there is no obligation. |
|
